Clinical Trial Update: Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS

View source ↗

Summary

A completed clinical trial evaluated whether a double daily dose of a GnRH antagonist could prevent ovarian hyperstimulation syndrome in hyperresponding IVF/ICS…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Snippet

Sponsor: Iakentro Fertility Centre | Conditions: Ovarian Hyperstimulation Syndrome | Status: COMPLETED